Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice

Circulation

Volumn 96, Issue 12, 1997, Pages 4333-4342

  Kumar, Anjali ^a   Hoover, Jennifer L ^c   Simmons, Carol A ^c   Lindner, Volkhard ^c   Shebuski, Ronald J ^b  

^a Preclin R and D Genetics Institute   (United States)

^b PFIZER INC   (United States)

^c NONE

Author keywords

Cells; Immunohistochemistry; Remodeling; Restenosis

Indexed keywords

CD45 ANTIGEN; PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY; CAROTID ARTERY LIGATION; CONTROLLED STUDY; INFLAMMATORY INFILTRATE; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031469109     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4333     Document Type: Article

References (60)

1. Marmur JD, Merlini PA, Sharma SK, Khaghan N, Torre SR, Israel DH, Ardissino D, Ambrose JA. Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty. J Am Coll Cardiol. 1994;24:1484-1491.
2. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimai formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
3. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
4. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816-2821.
5. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol. 1994;74:1278-1280.
6. Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 1995;92:2995-3005.
7. Andersen HR, Maeng M, Thorwest M, Falk E. Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury: insights from a porcine coronary (re)stenosis model. Circulation. 1996;93:1716-1724.
8. Guyton JR, Hartley CJ. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am J Physiol. 1985;248:H540-H546.
9. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in flow are endothelium-dependent. Science. 1986;231:405-407.
10. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am J Physiol. 1980;239: H14-H21.
11. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 1985;101:880-886.
12. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest. 1986;78:130-137.
13. McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in the Weibel-Palade bodies. J Clin Invest. 1989;84:92-99.
14. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM (GMP 140) is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1989;73:1109-1112.
15. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science. 1992;258:964-969.
16. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
17. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 1989;59:305-312.
18. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 1990;75:550-554.
19. McEver RP. Regulation of function and expression of P-selectin. Agents Actions Suppl. 1995;47:117-119.
20. De Servi S, Mazzone A, Ricevuti G, Fioravanti A, Bramucci E, Angoli L, Stefano G, Speechia G. Granulocyte activation after coronary angioplasty in humans. Circulation. 1990;82:140-146.
21. Tsutsui M, Shimokawa H, Tanaka S, Yoshihara S, Higuchi S, Matsuguchi T, Okamatsu S. Granulocyte activation in restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J. 1996;60:27-34.
22. Ikeda H, Nakayama H, Oda T, Kuwano K, Yamaga A, Ueno T, Yoh M, Hiyamuta K, Koga Y, Toshima H. Neutrophil activation after percutaneous transluminal coronary angioplasty. Am Heart J. 1994;128:1091-1098.
23. Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol. 1996;28:345-353.
24. Ishiwata S, Tukada T, Nakanishi S, Nishiyama S, Seki A. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J. 1997;133:387-392.
25. Redl H, Hammerschmidt DE, Schlag G. Augmentation by platelets of granulocyte aggregation in response to chemotaxins: studies utilizing an improved cell preparation technique. Blood. 1983;61:125-131.
26. Tzeng DY, Deuel TF, Huang JS, Senior RM, Boxer LA, Baehner RL. Platelet-derived growth factor promotes polymorphonuclear leukocyte activation. Blood. 1984;64:1123-1128.
27. Marcus AJ, Safier LB, Ullman HL, Broekman MJ, Islam N, OglesbyTD, German RR. 12S,20-Dihydroxyicosatetraenoic acid: a new icosanoid synthesized by neutrophils from 12S- hydroxyicosatetraenoic acid produced by thrombin- or collagenstimulated platelets. Proc Natl Acad Sci U S A. 1984;81:903-907.
28. 4. J Biol Chem. 1988;263:2223-2229.
29. Celi A, Pellegrini G, Lorenzo R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 1994;91:8767-8771.
30. Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis. 1995;6(suppl 1):S20-S25.
31. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
32. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of flow. Arterioscler Thromb Vasc Biol. 1997;17:2238-2244.
33. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res. 1993;73:792-796.
34. Dejana E, Callioni A, Quintana A, de Gaetano G. Bleeding time in laboratory animals, II: a comparison of different assay conditions in rats. Thromb Res. 1979;15:191-197.
35. Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD. Defects in hemostasis in P-selectin-deficient mice. Blood. 1996;87:1238-1242.
36. Wagner DD. P-selectin knockout: a mouse model for various human diseases. CIBA Found Symp. 1995;189:2-16.
37. 3 integrin with a small peptide antagonist GpenGRGDSPCA. L Vasc Surg. 1994;19:125-134.
38. Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL, Willerson JT, on behalf of the EPIC Investigators. Randomised trial of coronary intervention with antibody against platelet Ilb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet. 1994;343:881-886.
39. Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J Vasc Surg. 1987;5:393-400.
40. Langille BL, Bendeck MP, Keeley FW. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am J Physiol. 1989;256:H931-H939.
41. Glagov S. Intimal hyperplasia, vascular remodeling, and the restenosis model. Circulation. 1994;89:2888-2891.
42. Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 1993;74:541-554.
43. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA. 1987;84:9238-9242.
44. Diacovo TG, Puri KD, Warnock RA, Springer TA, von Adrian UH. Platelet-mediated lymphocyte delivery to high endothelial venules. Science. 1996;273:252-255.
45. 2integrin CD11b/CD18. Blood. 1996;88:146-157.
46. Issekutz AC, Ripley M, Jackson JR. Role of neutrophils in the deposition of platelets during acute inflammation. Lab Invest. 1983;49:716-724.
47. 111In-labelled platelet accumulation in infarcted myocardium. J Cardiovasc Pharmacol. 1985;7:906-912.
48. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
49. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Adrian UH, Hübner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 1994;71:380-386.
50. Rinder CS, Bonan JL, Rinder HM, Mathew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 1992;79:1201-1205.
51. Hirosumi J. Nomoto A, Ohkubo Y, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H. Inflammatory responses in cuff-induced atherosclerosis in rabbits. Atherosclerosis. 1987;64:243-254.
52. Kling D, Holzschuh T, Betz E. Recruitment and dynamics of leukocytes in the formation of arterial intimal thickening: a comparative study with normo- and hypcrcholesterolemic rabbits. Atherosclerosis. 1993;101:79-96.
53. Welply JK, Keene JL, Schmuke JJ. Howard SC. Selectins as potential targets of therapeutic intervention in inflammatory diseases. Biochim Biophys Acta. 1994;1197:215-226.
54. Weyrich AS, Ma X, Lofer DJ, Alhertine KH, Lefer AM. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest. 1993;91:2620-2629.
55. Winn RK, Liggitt D, Vedder NB, Paulson JC, Harlan JM. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin Invest. 1993;92:2042-2047.
56. Seekamp A. Till GO, Mulligan MS, Paulson JC, Anderson DC, Miyasaka M, Ward PA. Role of selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol. 1994;144:592-598.
57. Silver MJ, Sutton JM, Hook S, Lee P, Malycky JL, Phillips L, Ellis SG, Topol EJ, Nicolini FA. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation. 1995;92:492-499.
58. Toombs CF, Degraaf GL, Martin JP, Geng JG, Andcrson DC, Shebuski RJ. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thromholysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther. 1995;275:941-949.
59. Barron MK, Lefer DJ, Lake RS, Buda AJ, Tenaglia AN. Intimal hyperplasia following balloon injury is reduced by blocking selectins: a possible role for cell adhesion molecules in restenosis. Circulation. 1996;949(suppl I):I-42. Abstract.
60. Eppihimer MJ, Wolitzky B, Anderson DC, Labow MA, Granger DN. Heterogeneity of expression of E- and P-selectins in vivo. Circ Res. 1996;79:560-569.